It’s not an easy environment for health-care investors, with the sector front and center of political debates, but a bigger concern might be stemming from a key regulator: the U.S. Food and Drug Administration.

The STADA Group, a global manufacturer of high-quality generic drugs and consumer healthcare products, continues its growth trajectory in Europe. The company, headquartered in Germany, announced today that it is acquiring the pharmaceutical business of Biopharma, one of the key pharmaceutical producers in Ukraine.

Research conducted on human pancreatic tumors transplanted in mice reveals promising results, TAU researchers say

A new study shows how tiny robotic vessels powered by acoustic waves and an on-board bubble motor can be maneuvered through cellular landscapes using magnets.